Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: herceptin|DRUG: adriamycin|DRUG: cyclophosphamide|DRUG: taxol
Sponsor: NSABP Foundation Inc
Collaborators: National Cancer Institute (NCI)